Vitamina D y salud ósea en la mujer posmenopáusica. Revisión
PDF
HTML

Palabras clave

Vitamina D
osteoporosis
densidad mineral ósea
hiperparatiroidismo secundario
sarcopenia
vitamin D
bone mineral density
secondary hyperparathyroidism

Cómo citar

Rosero Olarte, O. (2017). Vitamina D y salud ósea en la mujer posmenopáusica. Revisión. Revista Colombiana De Endocrinología, Diabetes &Amp; Metabolismo, 2(1), 14–19. https://doi.org/10.53853/encr.2.1.66

Resumen

La vitamina D es un determinante importante de la salud ósea y de la función neuromuscular. Recientemente se ha catalogado el déficit de vitamina D como un problema epidémico de proporción mundial.
Evidencia reciente sugiere que el aporte de vitamina D en dosis suficiente disminuye el riesgo de fracturas, así como el riesgo de presentar caídas en pacientes ancianos.
Mantener un nivel adecuado de vitamina D es una práctica simple y poco costosa que contribuye a disminuir las consecuencias que su déficit representa para la salud ósea.

Abstract
Vitamin D is an important determinant of bone health and neuromuscular function. Vitamin D deficiency is now recognized as a worldwide epidemic.
Recent evidence suggests that vitamin D intake in a sufficient dose decreases the risk of fractures and falls among elderly patients.
It takes a simple and low-cost practice to maintain vitamin D at suitable levels, thus contributing to decrease the consequences that its deficit entails for bone health.

https://doi.org/10.53853/encr.2.1.66
PDF
HTML

Citas

1. Holick MF. Vitamin D: Photobiology, metabolism, mechanism of action, and clinical applications. Flavus M. editor. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. American society for Bone and Mineral Research. Washington D.C. 2003; 129-137.
2. Holick MF. Vitamin D Deficiency. N Engl J Med 2007; 357:266-281.
3. Dusso A, Brown J, Slatopolsky E. Vitamin D. Am J Renal Physiol; 2005; 289: F8-F28.
4. Bouillon R. Vitamin D From photosyntesis, metabolism and action to clinical applications. De Groot LJ, Jamerson LJ. editors. Endocrinology. Philadelphia; WB Saunders; 2001; 1009-1035.
5. Kurnik B, Hruska K. Mechanism of stimulation of renal phosphate transport by 1,25-dihydroxycholecaiciferol. Biochim Biophys Acta; 1985; 817: 42-50.
6. Lips P. Vitamin D Deficiency and Secondary Hyperparathyroidism in the Elderly: Consequences for Bone Loss and Fractures and Therapeutic Implications. Endocrine Reviews; 2001; 22(4): 477-501.
7. Stejskal D, Bartek J, Pastrokova R, et al. Osteoprotegerin, RANK, RANKL. Biomed Papers; 2001; 145:61-64.
8. Lips P. The effect of vitamin D supplementation on vitamin D status and Parathyroid Function in elderly subjects. J Clin Endocrinol Metab; 1988; 67: 644-650.
9. Bruce D, St John A, Nicklason F, et al. Secondary Hyperparathyroidism in Patients from Western Australia with Hip Fracture: Relationship to Type of Hip Fracture, Renal Function, and Vitamin D Deficiency. J American Geriat rics Society; 1999; 47 (3): 354-359.
10. Chapuy MC, Preziosi P, Maamer M, et al. Prevalence of Vitamin D Insufficiency in an Adult Normal Population. Osteoporos Int; 1997; 7:439-443.
11. Okumus M, Koybas? M, Tuncay F, et al Fibromyalgia syndrome: is it related to vitamin D deficiency in premenopausal female patients? Pain Manag Nurs. 2013 Dec;14(4):e156-161.
12. Jesus CA, Feder D, Peres MF. The role of vitamin D in pathophysiology and treatment of fibromyalgia. Curr Pain Headache Rep. 2013; 17(8):355-362.
13. Guilsun Kim, Ki Won Oh, Eun-Hee Jang et al. Relationship between Vitamin D, Parathyroid Hormone, and Bone Mineral Density in Elderly Koreans. J Korean Med Sci 2012; 27: 636-643.
14. Le Boff MS, Kohlmeier L, Hurwitz S. Occult vitamin D deficiency in postmenopausal US woman with acute hip fracture. JAMA; 1999; 281:1505-1511.
15. Kristin Holvik, Luai A. Ahmed, Siri Forsmo. Low Serum Levels of 25-Hydroxyvitamin D Predict Hip Fracture in the Elderly: A NOREPOS Study J Clin Endocrinol Metab 2013 98:8, 3341-3350.
16. Alfonso J. Cruz-Jentoft1, Jean Pierre Baeyens, Jürgen M. Bauer et al Sarcopenia: European consensus on definition and diagnosisReport of the European Working Group on Sarcopenia in Older People. Age Ageing 2010: 39 (4): 412-423.
17. Holick MF. High prevalence of vitamin D inadequacy and implications for Health. Mayo Clin Proc; 2006; 81: 353-373.
18. Christian M. Girgis, Roderick J. Clifton-Bligh et al. The Roles of Vitamin D in Skeletal Muscle: Form, Function, and Metabolism. Endocr Rev. 2013 Feb;34(1):33-83.
19. Dawson H, Heaney RP, Holick MF. Estimation of optimal vitamin D status. Osteoporos Int; 2005; 16: 713-716.
20. Priemel M. Von Domarus C, Klatte TO. Bone mineralization defects and vitamin D deficiency: Histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675?patients. J Bon Miner Res 2010; 25, 2, :305–312.
21. Holick MF, Siris E, Binkley N. Prevalence of Vitamin D Inadequacy among Postmenopausal North American Women Receiving Osteoporosis Therapy. J Clin Endocrinol Metab; 2005; 90: 3215-3224.
22. Nesby-O’Dell S, Scanlon K, Cogswell M. et al. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age. Am J Clin Nutr; 2002; 76: 187-192.
23. Rodríguez J, Valdivia G, Trincado P. Fracturas vertebrales osteoporosis y vitamina D en la postmenopausia. Estudio en 555 mujeres en Chile. Rev Med Chile; 2007; 135: 31-36.
24. Binkley N, Novotny R, Krueger D. Low Vitamin D Status despite Abundant Sun Exposure. J Clin Endocrinol Metab; 2007; 92: 2130-2135.
25. Deyanira, González Devia; Claudia, Zúñiga Libreros; William, Kattah Calderón. Insuficiencia de vitamina D en pacientes adultos con baja masa ósea y osteoporosis en la Fundación Santa Fe de Bogotá 2008-2009 / Vitamin D insufficiency in adults patients with low bone mass and osteoporosis in the Fundación Santa Fe de Bogotá 2008-2009. Rev.Colomb.Reumatol.; 17(4); 212-218; 2010-09
26. Molina JF, Molina J, Jorge, Escobar JA. et al Niveles de 25 hidroxivitamina D y su correlación clínica con diferentes variables metabólicas y cardiovasculares en una población de mujeres posmenopáusicas. Acta Med Colomb 2011; 36: 18-23.
27. María Patricia, Hormaza; Diana, Cuesta; Lina María, Martínez; Mónica María, Massaro; María Nazareth, Campo; María del Pilar, Vélez; Gabriel Jaime, Rendón; Camilo Andrés, Agudelo. Niveles séricos de 25 hidroxivitamina d en mujeres no menopáusicas, menopáusicas y posmenopáusicas. Rev Colomb Obstet Ginecol; 62(3); 231-236; 2011-09.
28. Chel VGM, Ooms ME, Pooo-Snijders L, et al. Ultraviolet Irradiation Corrects Vitamin D Deficiency and Suppresses Secondary Hyperparathyroidism in the Elderly. J Bone Miner Res; 1998; 13: 1238-1242.
29. The American Academic of dermatology. Position Statement on Vitamin D. http://www.aad.org/Forms/Policies/Uploads/PS/PSVitamin%20D%20 Postition%20Statement.pdf
30. Brazier M, Kamel S, Maamer M. et al. Markers of bone remodelling in the elderly subject: effects of vitamin d insufficiency and its correction. J Bone Miner Res; 1995; 10: 1753-1761.
31. Prestwood KM, Pannullo AM, Kenny AM, et al. The effect of a short course of calcium and vitamin D on bone turnover in older women. Osteoporos Int; 1996; 6:314-319.
32. Sakalli H, Arslan D , Yucel AE. The efect of oral and parenteral vitamin D supplementation in the elderly: a prospective, double-blinded, randomized, placebo-controlled study.; Rheumatol Int; 2012: 32:2279–2283.
33. Grimnes G, Joakimsen R, Figenschau Y, Torjesen PA, Almås B, Jorde R. The effect of high-dose vitamin D on bone mineral density and bone turnover markers in postmenopausal women with low bone mass--a randomized controlled 1-year trial. Osteoporos Int. 2012: 23(1):201-11.
34. Ooms M, Roos J, Bezemer P, et al. Prevention of bone loss by Vitamin D supplementation in elderly women: a randomized double-blind trial. J Clin Endocrinol Metab; 1995; 80:1052-1058.
35. Reid IR, Bolland MJ, Grey A. Effects of vitamin D supplements on bone mineral density: a systematic review and meta-analysis. Lancet. 2014 11;383 (9912):146-55.
36. Boonen S, Bischoff F, Cooper C, et al. Addressing the musculoskeletal components of fracture risk with calcium and vitamin D: a review of the evidence. Calcif Tissue Int; 2006; 78: 257-270.
37. Murad MH, Elamin KB, Abu Elnour NO, Elamin MB, Alkatib AA, Fatourechi MM et al. Clinical review: The effect of vitamin D on falls: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2011; 96(10):2997-3006
38. Kattah W. Epidemiología de osteoporosis algunos datos de la población mundial. Revista Colombiana de Menopausia; 1995; 1 (2) 33-35.
39. Bischoff H, Willett W, Wong J, et al. Fracture prevention With vitamin D supplementation. JAMA; 2005; 293; 2257-2264.
40. Heike A. Bischoff F, Walter C. Willett, E,Lips P, Meunier PJ, Ronan A. et al. A Pooled Analysis of Vitamin D Dose Requirements for Fracture Prevention. N Engl J Med 2012; 367:40-49.
41. Holick MF, Binkley N, Bischoff-Ferrari, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, Treatment, and Prevention of Vitamin D Deficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2011, 96(7):1911–1930.
42. Fahad Alshahrani, Naji Aljohani. Vitamin D: Deficiency, Sufficiency and Toxicity. Nutrients. 2013; 5 (9):3605-3616.
Los autores deben declarar revisión, validación y aprobación para publicación del manuscrito, además de la cesión de los derechos de publicación, mediante un documento que debe ser enviado antes de la aparición del escrito.  Puede consultar una copia del documento aquí

Descargas

Los datos de descargas todavía no están disponibles.